
Read More
One of India's Largest Pharmaceutical Companies Receives EMA Approval to Ex...
The European Medicines Agency has approved Lupin's NaMuscla for paediatric patients with non-dystrop...

The European Medicines Agency has approved Lupin's NaMuscla for paediatric patients with non-dystrop...

This article is authored by Ms Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd...

The company reported a net profit of Rs. 9.49 crore for FY23, exhibiting a remarkable year-on-year g...